KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Invested Capital (2016 - 2025)

Historic Invested Capital for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Chemed's Invested Capital fell 1287.25% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1287.25%. This contributed to the annual value of $1.1 billion for FY2024, which is 100.35% up from last year.
  • As of Q3 2025, Chemed's Invested Capital stood at $1.1 billion, which was down 1287.25% from $1.2 billion recorded in Q2 2025.
  • Chemed's Invested Capital's 5-year high stood at $1.2 billion during Q3 2024, with a 5-year trough of $623.3 million in Q4 2021.
  • Over the past 5 years, Chemed's median Invested Capital value was $952.1 million (recorded in 2023), while the average stood at $960.9 million.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 3083.97% in 2021, then skyrocketed by 4031.12% in 2023.
  • Over the past 5 years, Chemed's Invested Capital (Quarter) stood at $623.3 million in 2021, then rose by 28.95% to $803.7 million in 2022, then soared by 37.84% to $1.1 billion in 2023, then rose by 1.0% to $1.1 billion in 2024, then decreased by 3.78% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.